New Pharma, Inc. – Trademark Portfolio

Entity Type: 03

New Pharma, Inc. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 13 filings in this category. Currently, 7 trademarks are registered. Notable registered marks include MAXPRO, ALMEBEX, GUAIFED, LIDONEX, and VENATON. The owner is based in Miami, FL.

3307 NW 74th Avenue

Miami, FL 33122

13 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

RENALVIT
RENALVIT
Abandoned 2025
GUAIFED
GUAIFED
Registered 2025
MAXPRO
MAXPRO
Registered 2025
VAGITROL
VAGITROL
Abandoned 2022
VIOFORM
VIOFORM
Abandoned 2022
LIDONEX
LIDONEX
Registered 2022
FEOSTAT
FEOSTAT
Abandoned 2021
VENATON
VENATON
Registered 2018
VENIPHLEX
VENIPHLEX
Registered 2018
ALMEBEX
ALMEBEX
Registered 2013

Trademark Classifications

New Pharma, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (13 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does New Pharma, Inc. have?

New Pharma, Inc. has 13 U.S. trademarks filed with the USPTO. Of these, 7 registered, 4 abandoned, 2 cancelled.

What trademark classes does New Pharma, Inc. file in?

New Pharma, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are New Pharma, Inc.'s most well-known trademarks?

New Pharma, Inc.'s registered trademark portfolio includes well-known marks such as MAXPRO, ALMEBEX, GUAIFED, LIDONEX, and VENATON. These are among 7 currently registered trademarks in the portfolio.

What is New Pharma, Inc.'s trademark registration success rate?

New Pharma, Inc. has a 54% trademark registration rate, with 7 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.